Incidence of Plasmodium falciparum malaria infection in 6-month to 45-year-olds on selected areas of Bioko Island, Equatorial Guinea.
Bioko Island
Equatorial Guinea
Incidence
Malabo
Malaria
PfSPZ Vaccine
Plasmodium falciparum
Journal
Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802
Informations de publication
Date de publication:
20 Jul 2021
20 Jul 2021
Historique:
received:
07
05
2021
accepted:
11
07
2021
entrez:
21
7
2021
pubmed:
22
7
2021
medline:
6
11
2021
Statut:
epublish
Résumé
Extensive malaria control measures have been implemented on Bioko Island, Equatorial Guinea over the past 16 years, reducing parasite prevalence and malaria-related morbidity and mortality, but without achieving elimination. Malaria vaccines offer hope for reducing the burden to zero. Three phase 1/2 studies have been conducted successfully on Bioko Island to evaluate the safety and efficacy of whole Plasmodium falciparum (Pf) sporozoite (SPZ) malaria vaccines. A large, pivotal trial of the safety and efficacy of the radiation-attenuated Sanaria A cohort of 240 randomly selected individuals aged 6 months to 45 years from selected areas of North Bioko Province, Bioko Island, was followed for 24 weeks after clearance of parasitaemia. Assessment of clinical presentation consistent with malaria and thick blood smears were performed every 2 weeks. Incidence of first and multiple malaria infections per person-time of follow-up was estimated, compared between age groups, and examined for associated socio-demographic risk factors. There were 58 malaria infection episodes observed during the follow up period, including 47 first and 11 repeat infections. The incidence of malaria was 0.25 [95% CI (0.19, 0.32)] and of first malaria was 0.23 [95% CI (0.17, 0.30)] per person per 24 weeks (0.22 in 6-59-month-olds, 0.26 in 5-17-year-olds, 0.20 in 18-45-year-olds). Incidence of first malaria with symptoms was 0.13 [95% CI (0.09, 0.19)] per person per 24 weeks (0.16 in 6-59-month-olds, 0.10 in 5-17-year-olds, 0.11 in 18-45-year-olds). Multivariate assessment showed that study area, gender, malaria positivity at screening, and household socioeconomic status independently predicted the observed incidence of malaria. Despite intensive malaria control efforts on Bioko Island, local transmission remains and is spread evenly throughout age groups. These incidence rates indicate moderate malaria transmission which may be sufficient to support future larger trials of PfSPZ Vaccine. The long-term goal is to conduct mass vaccination programmes to halt transmission and eliminate P. falciparum malaria.
Sections du résumé
BACKGROUND
BACKGROUND
Extensive malaria control measures have been implemented on Bioko Island, Equatorial Guinea over the past 16 years, reducing parasite prevalence and malaria-related morbidity and mortality, but without achieving elimination. Malaria vaccines offer hope for reducing the burden to zero. Three phase 1/2 studies have been conducted successfully on Bioko Island to evaluate the safety and efficacy of whole Plasmodium falciparum (Pf) sporozoite (SPZ) malaria vaccines. A large, pivotal trial of the safety and efficacy of the radiation-attenuated Sanaria
METHODS
METHODS
A cohort of 240 randomly selected individuals aged 6 months to 45 years from selected areas of North Bioko Province, Bioko Island, was followed for 24 weeks after clearance of parasitaemia. Assessment of clinical presentation consistent with malaria and thick blood smears were performed every 2 weeks. Incidence of first and multiple malaria infections per person-time of follow-up was estimated, compared between age groups, and examined for associated socio-demographic risk factors.
RESULTS
RESULTS
There were 58 malaria infection episodes observed during the follow up period, including 47 first and 11 repeat infections. The incidence of malaria was 0.25 [95% CI (0.19, 0.32)] and of first malaria was 0.23 [95% CI (0.17, 0.30)] per person per 24 weeks (0.22 in 6-59-month-olds, 0.26 in 5-17-year-olds, 0.20 in 18-45-year-olds). Incidence of first malaria with symptoms was 0.13 [95% CI (0.09, 0.19)] per person per 24 weeks (0.16 in 6-59-month-olds, 0.10 in 5-17-year-olds, 0.11 in 18-45-year-olds). Multivariate assessment showed that study area, gender, malaria positivity at screening, and household socioeconomic status independently predicted the observed incidence of malaria.
CONCLUSION
CONCLUSIONS
Despite intensive malaria control efforts on Bioko Island, local transmission remains and is spread evenly throughout age groups. These incidence rates indicate moderate malaria transmission which may be sufficient to support future larger trials of PfSPZ Vaccine. The long-term goal is to conduct mass vaccination programmes to halt transmission and eliminate P. falciparum malaria.
Identifiants
pubmed: 34284778
doi: 10.1186/s12936-021-03850-8
pii: 10.1186/s12936-021-03850-8
pmc: PMC8290541
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
322Informations de copyright
© 2021. The Author(s).
Références
Malar J. 2019 Jan 15;18(1):9
pubmed: 30646918
Am J Trop Med Hyg. 1994 May;50(5):529-36
pubmed: 7911282
Lancet Infect Dis. 2017 May;17(5):498-509
pubmed: 28216244
PLoS One. 2017 Jul 5;12(7):e0179528
pubmed: 28678846
Hum Vaccin. 2010 Jan;6(1):97-106
pubmed: 19946222
Malar J. 2018 Feb 5;17(1):62
pubmed: 29402288
J Infect Dis. 2014 Jul 15;209 Suppl 3:S107-13
pubmed: 24966190
Am J Trop Med Hyg. 2002 Mar;66(3):280-6
pubmed: 12139221
Int J Health Geogr. 2006 Jun 19;5:27
pubmed: 16784527
Malar J. 2019 Nov 20;18(1):368
pubmed: 31747974
PLoS Negl Trop Dis. 2011 Jun;5(6):e1192
pubmed: 21713024
Am J Trop Med Hyg. 2020 Sep;103(3):947-954
pubmed: 32458790
Clin Infect Dis. 2013 Jul;57(1):40-7
pubmed: 23487390
Am J Trop Med Hyg. 2018 Jan;98(1):308-318
pubmed: 29141739
Nature. 2017 Feb 23;542(7642):445-449
pubmed: 28199305
Malar J. 2014 Aug 23;13:330
pubmed: 25149656
Clin Infect Dis. 2020 Dec 31;71(11):2849-2857
pubmed: 31782768
Am J Trop Med Hyg. 2010 Sep;83(3):465-73
pubmed: 20810805
Malar J. 2015 Feb 05;14:46
pubmed: 25651929
Acta Trop. 2017 Nov;175:78-83
pubmed: 28336268
Malar J. 2018 Oct 25;17(1):384
pubmed: 30359255
Malar J. 2019 Apr 18;18(1):141
pubmed: 30999957
PLoS Med. 2011 Jan 25;8(1):e1000398
pubmed: 21311586
Am J Trop Med Hyg. 2014 Sep;91(3):471-480
pubmed: 25070995
Malar J. 2017 Jan 26;16(1):48
pubmed: 28126001
Trop Med Int Health. 2004 Aug;9(8):862-8
pubmed: 15303990
Lancet. 2013 Sep 7;382(9895):900-11
pubmed: 23594387
Nurs Stand. 2002 Jun 19-25;16(40):33-6
pubmed: 12216297
Am J Trop Med Hyg. 1999 Feb;60(2):183-7
pubmed: 10072133
PLoS Med. 2014 Jul 29;11(7):e1001685
pubmed: 25072396
Nat Commun. 2019 May 27;10(1):2332
pubmed: 31133635
Acta Trop. 2002 Nov;84(2):83-92
pubmed: 12429425
J Med Entomol. 2019 Jun 27;56(4):1071-1077
pubmed: 30882148
PLoS One. 2012;7(4):e35592
pubmed: 22558172
Malar J. 2019 Aug 22;18(1):283
pubmed: 31438979